Status:

COMPLETED

Efficacy Study of Bowel Preparation Before Colonoscopy

Lead Sponsor:

C.B. Fleet Company, Inc.

Conditions:

Bowel Cleansing Prior to Colonoscopy

Eligibility:

All Genders

50+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine the efficacious dose range when used as a bowel preparation before colonoscopy.

Eligibility Criteria

Inclusion

  • Men and nonpregnant women who are scheduled for an elective colonoscopy and who are at least 50 years of age.
  • Are able to communicate with study personnel and comply with study requirements.
  • Are able and willing to follow study-specified testing, diet, and hydration regimen.
  • Have been informed of the nature and risks of the study and have given written informed consent.

Exclusion

  • Have known or suspected liver disease or any history of abnormal liver function tests.
  • Have clinically active cardiovascular disease within the past 6 months.
  • Have blood pressure greater than 150/90 mm Hg.
  • Have known or suspected renal insufficiency.
  • Have known or suspected electrolyte abnormalities, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Have a history of prior bowel surgery within 2 years before enrollment, or active inflammatory bowel disease.
  • Have diabetes or a history of diabetes.
  • Have clinical evidence of dehydration.
  • Are pregnant or breast-feeding.
  • Are unwilling to abstain from alcohol consumption from one day before colonoscopy until discharged from the study.
  • Use prohibited medications of the study in the defined timeframes.
  • Have received any investigational agent within 30 days before dosing.
  • Have any known contraindications to the study treatment.
  • Have any known or suspected allergies to the components of the study medication.
  • Have any other condition which would make the subject unsuitable for inclusion in the study.

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2008

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT00621920

Start Date

January 1 2008

End Date

April 1 2008

Last Update

February 10 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Advanced Clinical Research Institute

Anaheim, California, United States, 92801

2

Qualia Clinical Services

Omaha, Nebraska, United States, 68154